Apotea up 71% since two insiders bought shares
- Insider
- Laulima
- Role
- Closely associated: Chief Executive Officer
- Company
- Apotea (APOTEA)
- Transaction
- Buy
- Shares
- 475,000
- Amount
- SEK 29.7M
- Price per share
- SEK 62.55
- Trade date
- Feb 4, 2026
- Filed
- Feb 4, 2026, 0 days after the trade
- Source
- Finansinspektionen ↗
Laulima, closely associated with the CEO of Apotea, bought 475,000 shares at SEK 62.55 on Feb 4, 2026, for SEK 29.7M. The stock traded at SEK 103.00 on Nov 5, 70.6% above the first close after the purchase.
The purchase was reported to Finansinspektionen the same day. Another Apotea insider, Tromelin, also disclosed a purchase on Feb 4, 2026. No sales by Laulima in Apotea have been reported since.
The first close after the purchase was SEK 60.39 on Feb 5, 2026. The price of SEK 103.00 was recorded at 12:33 CET on Nov 5, delayed by 15 to 20 minutes.
APOTEA +7.0% on the day, delayed quote Nov 5
Since purchase+70.6%SEK 60.39 → SEK 103.00 at 12:33 CET
Since filing+70.6%SEK 60.39 on Feb 5 → SEK 103.00
PurchaseSEK 29.7M475,000 shares on Feb 4, 2026
Days since purchase274No sales by this filer since
Price since the purchase
Daily close · SEK+70%
0%
Feb 5 · first close 60.39 SEKNov 5 · 103.00 SEK
PurchaseFirst close above +70%